Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ Quantitative Report
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Albany Molecular Research Inc Issues Q4 2012 EPS Guidance Above Analysts' Estimates; Raises FY 2012 EPS Guidance


Tuesday, 6 Nov 2012 08:01am EST 

Albany Molecular Research Inc announced that for fiscal 2012, it expects adjusted earnings per diluted share (EPS) from a range of $0.10 to $0.16 to a range of $0.16 to $0.20. For fourth quarter of 2012, it expects adjusted earnings per diluted share (EPS) in the range of $0.08 to $0.12. According to I/B/E/S Estimates, analysts were expecting the Company to report earnings per share (EPS) of $0.06 for the fourth quarter of 2012; EPS of $0.12 for fiscal 2012. 

Company Quote

21.77
0.05 +0.23%
3:06pm EDT